Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Clinical research sponsor
Clinical trials
29 shownStudy of Dupilumab 300 mg Every Other Week After Endoscopic Sinus Surgery in Patients With Allergic Fungal Rhinosinusitis (AFRS) on a Background Therapy With Intranasal Corticosteroid SprayNCT06461949 · lead sponsor · 2024-07-17
WITHDRAWNCentral Mechanisms in Speech Motor Control Studied With H215O PETNCT00001308 · lead sponsor · 1992-04-28
TERMINATEDRandomized Study of Two Interventions for Liquid Aspiration: Short-Term and Long-Term EffectsNCT00000362 · lead sponsor
TERMINATEDInvestigating Subcortical Contributions to Speech Sequencing in Deep Brain Stimulator RecipientsNCT07455760 · collaborator · 2026-02-18
RECRUITINGAssessing Pharmacy Technician Educational Training for the Provision of Over-the-Counter Hearing Aids in Rural Alabama and Mississippi PharmaciesNCT06864273 · collaborator · 2025-07-25
RECRUITINGNeocortical Microarchitecture of Executive FunctionNCT06778135 · collaborator · 2025-07-25
RECRUITINGThe Impact of Deep Brain Stimulation on Speech and Swallow Function in Parkinson DiseaseNCT07026734 · collaborator · 2025-05-26
RECRUITINGListener Training for Improved Intelligibility of People With Parkinson's DiseaseNCT06815263 · collaborator · 2025-04-07
RECRUITINGOlfactory BiopsiesNCT07021040 · collaborator · 2025-01-06
RECRUITINGSpeech Amplification Devices for Parkinson Disease: Talker- and Technology-Driven EnhancementsNCT07599696 · collaborator · 2024-03-01
RECRUITINGCharacterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's DementiaNCT04240561 · collaborator · 2021-07-01
RECRUITINGECoG BMI for Motor and Speech ControlNCT03698149 · collaborator · 2018-11-09
RECRUITINGA Multidimensional Study on Articulation Deficits in Parkinsons DiseaseNCT05754086 · collaborator · 2021-09-09
COMPLETEDSubthalamic Nucleus Deep Brain Stimulation in Speech StudyNCT05493670 · collaborator · 2020-10-15
UNKNOWNTranscranial Magnetic Stimulation and Constraint Induced Language Therapy for Alzheimer DiseaseNCT04482179 · collaborator · 2020-02-19
COMPLETEDSpeech, Linguistic and Acoustic Markers in Parkinson's DiseaseNCT04273672 · collaborator · 2020-01-13
COMPLETEDHearing Aid and Individuals With Cognitive DisordersNCT04049643 · collaborator · 2019-12-01
COMPLETEDNeurofeedback in Alzheimer's DiseaseNCT03790774 · collaborator · 2019-06-06
TERMINATEDVoice Treatment for Parkinson's DiseaseNCT03700684 · collaborator · 2018-09-19
COMPLETEDPhysiological Flow of Liquids Used in Dysphagia Management (Neuro)NCT03192358 · collaborator · 2017-11-01
COMPLETEDAdolescent Master Protocol for Participants 18 Years of Age or Older - LiteNCT03279185 · collaborator · 2017-11-01
COMPLETEDA Systematic Investigation of Phonetic Complexity Effects on Articulatory Motor Performance in Progressive DysarthriaNCT03613038 · collaborator · 2017-07-15
COMPLETEDCough According to Stimulus Type in PDNCT02390089 · collaborator · 2015-04-01
COMPLETEDAdolescent Master Protocol for Participants 18 Years of Age and Older (AMP Up)NCT02119702 · collaborator · 2014-04-01
COMPLETEDRehabilitation and Prophylaxis of Anomia in Primary Progressive AphasiaNCT02675270 · collaborator · 2011-11-01
COMPLETEDHealth Behavior in School-Age Children: NEXT Longitudinal Study 2009-2016NCT01031160 · collaborator · 2010-02-17
COMPLETEDAdolescent Master ProtocolNCT01418014 · collaborator · 2007-03-01
COMPLETEDSurveillance Monitoring for ART Toxicities Study in HIV Uninfected Children Born to HIV Infected WomenNCT01310023 · collaborator · 2007-03-01
COMPLETEDEfficacy of Voice Treatment for Parkinson's DiseaseNCT00123084 · collaborator · 2002-03-01
COMPLETEDSponsor roles
collaborator26
lead sponsor3
How to interpret this record
CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.